Across TCGA pan-cancer cohorts, CFAP45 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CFAP45 data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CFAP45 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CFAP45 expression acts as an unfavorable survival marker, although some lineages such as UCEC and STAD show a favorable association.
UCEC, STAD, and PRAD are the cancer types where CFAP45 Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.